Multifunctional hyaluronic acid-modified hollow MnO

Chong Li, Wei Liu, Ningfu Li, Yanyan Zhang, Ke Wu, Shaohong Yu

Abstract read

In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chong LiOncology Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Wei LiuOncology Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Ningfu LiOncology Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Yanyan ZhangOncology Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Ke WuPharmacy Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Shaohong YuGeneral Surgery Department, The Affiliated Dazu's Hospital of Chongqing Medical University, No. 1073 Tangxiang Street, Chongqing, 400900, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high rates of recurrence and metastasis in colorectal cancer (CRC), coupled with its immunosuppressive tumor microenvironment (TME), severely constrain patient survival. To overcome the limitations of monotherapies, this study developed a multifunctional targeted nanoplatform (RLHMnH). This system consists of a hyaluronic acid (HA)-modified hollow manganese dioxide (H-MnO

Indexed as

Colorectal cancerHollow manganese dioxideL-arginineRegorafenibSynergistic therapy

Identifiers

PMID42602254

DOI10.1016/j.mtbio.2026.103495

PMCPMC13473967

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.